FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 4131775 · Received October 1, 2014

Report

Report Number
2124215-2014-14024
Event Type
Malfunction
Date Received
October 1, 2014
Date of Event
July 5, 2014
Report Date
July 14, 2014
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE DEVICE SYSTEM DETECTED A FAULT CODE, INDICATING VOLTAGE TOO LOW FOR REMAINING PROJECTED LONGEVITY. DEVICE DATA WAS SAVED TO A DISK FOR FURTHER EVALUATION. EVALUATION OF THE DATA CONFIRMED THE PRESENCE OF THE FAULT CODE, HOWEVER, INDICATED THAT THERAPY DELIVER WAS UNAFFECTED. IT WAS RECOMMENDED THAT THE DEVICE BE EXPLANTED AND RETURNED FOR RELIABILITY ANALYSIS, HOWEVER, THE DATA INDICATED WITH A HIGH LIKELIHOOD THAT THERE WAS SUFFICIENT RESERVE FOR THE DEVICE TO MAINTAIN NORMAL THERAPY FUNCTIONS FOR 28 DAYS TIME. THE HEALTH CARE PROFESSIONAL (HCP) REPORTED THAT THE PATIENT WITH THIS DEVICE SYSTEM WAS TERMINALLY ILL FOR AN UNRELATED REASON AND THERE WAS NO PLAN TO REPLACE THE DEVICE. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THIS CLINICAL OBSERVATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
612223 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 90 YR E110| 0180| 4470